Should You Buy Arca Biopharma Inc (ABIO) in Biotechnology Industry?

Thursday, September 24, 2020 2:10 PM | InvestorsObserver Analysts

Arca Biopharma Inc (ABIO) is near the bottom in its industry group according to InvestorsObserver. ABIO gets an overall rating of 8. That means it scores higher than 8 percent of stocks. Arca Biopharma Inc gets a 4 rank in the Biotechnology industry. Biotechnology is number 35 out of 148 industries.

Overall Score - 8
ABIO has an Overall Score of 8. Find out what this means to you and get the rest of the rankings on ABIO!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 8 means the stock is more attractive than 8 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Arca Biopharma Inc Stock Today?

Arca Biopharma Inc (ABIO) stock is down -0.89% while the S&P 500 is up 1.11% as of 2:08 PM on Thursday, Sep 24. ABIO is down -$0.04 from the previous closing price of $4.18 on volume of 646,634 shares. Over the past year the S&P 500 is higher by 9.65% while ABIO is down -23.33%. ABIO lost -$3.08 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Arca Biopharma Inc (ABIO) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Related Companies